Bioxyne Limited Stock

Equities

BXN

AU000000BXN6

Biotechnology & Medical Research

Delayed Australian S.E. 08:36:35 2024-05-27 pm EDT 5-day change 1st Jan Change
0.006 AUD 0.00% Intraday chart for Bioxyne Limited 0.00% -45.45%
Sales 2022 2.48M 1.66M Sales 2023 5.3M 3.54M Capitalization 38.03M 25.37M
Net income 2022 - 0 Net income 2023 -1M -667K EV / Sales 2022 2.22 x
Net cash position 2022 2.17M 1.45M Net cash position 2023 3.29M 2.19M EV / Sales 2023 6.55 x
P/E ratio 2022
-30.1 x
P/E ratio 2023
-13.9 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 22.01%
More Fundamentals * Assessed data
Dynamic Chart
1 month-25.00%
3 months-40.00%
6 months-45.45%
Current year-45.45%
More quotes
1 week
0.01
Extreme 0.005
0.01
1 month
0.01
Extreme 0.005
0.01
Current year
0.01
Extreme 0.005
0.02
1 year
0.01
Extreme 0.005
0.03
3 years
0.01
Extreme 0.005
0.04
5 years
0.01
Extreme 0.005
0.04
10 years
0.01
Extreme 0.005
0.14
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-05-18
Comptroller/Controller/Auditor - -
Members of the board TitleAgeSince
Chairman 65 12-10-29
Director/Board Member - 23-05-18
Chief Executive Officer - 23-05-18
More insiders
Date Price Change Volume
24-05-27 0.006 0.00% 1 083 182
24-05-27 0.006 0.00% 1,636
24-05-24 0.006 0.00% 328
24-05-23 0.006 0.00% 2
24-05-21 0.006 0.00% 384,817

Delayed Quote Australian S.E., May 27, 2024 at 08:36 pm EDT

More quotes
Bioxyne Limited is an Australia-based international consumer health and pharmaceutical company. The Company is focused on health and wellness products, psychotropic and investigational medicines. The Company operates through three segments: Wholesale PCC/USA, Consumer Health Products UK/ EU/JPN, and Pharmaceuticals AUS. Its subsidiary, Breathe Life Sciences (BLS) manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabidiol (CBD), cannabis extracts, vitamins, manuka honey, skin care products and mushroom complexes. BLS operates in Australia, the United Kingdom, Japan, and Europe with four accredited manufacturing facilities across four countries Japan, Australia, the United Kingdom, and Czechia. The Company direct sales arm and has developed a range of functional food products containing ingredients sourced exclusively from New Zealand and sold in Asia.
More about the company